Evidence map›Paper›PMID 33652548›Full record

ReviewMolecules (Basel, Switzerland)2021

Probiotics in Cosmetic and Personal Care Products: Trends and Challenges.

Scarlett Puebla-Barragan, Gregor Reid

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Journal of microbiology and biotechnology · 2026
    Article
  7. Article
  8. Catechin and Phenolic Profiles of Fermented Miang (Antioxidants (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Lyophilized Cell-Free Supernatants ofLife (Basel, Switzerland) · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scarlett Puebla-BarraganCentre for Human Microbiome and Probiotics, Lawson Health Research Institute, London, ON N6C 2R5, Canada.ORCID 0000-0002-0276-3373
Gregor ReidCentre for Human Microbiome and Probiotics, Lawson Health Research Institute, London, ON N6C 2R5, Canada.ORCID 0000-0001-9658-5696

Funding

Consejo Nacional de Ciencia y Tecnología 692895
6 · The paper itself

Abstract

Probiotics, defined as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host," are becoming increasingly popular and marketable. However, too many of the products currently labelled as probiotics fail to comply with the defining characteristics. In recent years, the cosmetic industry has increased the number of products classified as probiotics. While there are several potential applications for probiotics in personal care products, specifically for oral, skin, and intimate care, proper regulation of the labelling and marketing standards is still required to guarantee that consumers are indeed purchasing a probiotic product. This review explores the current market, regulatory aspects, and potential applications of probiotics in the personal care industry.

Indexed as

CosmeticsCosmetic TechniquesHumansIndustryProbioticsCosmeticscosmeticslysatesmicrobiomeprobioticsskinvaginal health

Identifiers

PMID33652548
PMCPMC7956298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.